SIEMENS/BIOSENSE WEBSTER TO CREATE 3D HEART IMAGES.
"As doctors explore new ways to treat heart conditions with catheter-based procedures, they need clear and precise images of the heart to guide them," said Manfred Fink, vice president, Angiography and X-ray Division, Siemens Medical Solutions. "The combination of accurate cardiac images from Siemens' imaging systems with precise electroanatomical data from Biosense Webster's mapping systems will create unprecedented dimensional pictures to aid in the diagnosis and treatment of arrhythmias and other heart disorders."
To create these comprehensive images, the research team will combine real- time electroanatomical mapping data from Biosense Webster's CARTO(TM) XP EP Navigation and Ablation System with pre-procedural anatomical cardiac images provided by Siemens' magnetic resonance (MR) and computed tomography (CT) technologies. Electroanatomical mapping traces the movement of electrical signals through the heart. With the CARTO XP system, sensors located at the tip of specially designed catheters acquire data at various points within the heart to pinpoint the locations of irregular rhythms, or arrhythmias. Combining MR/CT images with electroanatomical mapping data produces a detailed 3D representation that shows the precise location of the erratic electrical signals in that patient's heart.
In the future, researchers will also use the AXIOM Artis dFC Magnetic Navigation System(TM) which integrates Siemens' most advanced digital fluoroscopic imaging system - the AXIOM Artis dFC (Flat Panel Detector System) - with the Niobe(R) Magnetic Navigation System from Stereotaxis Inc. This combination will allow direct magnetic steering of catheter- and guidewire- based devices along complex paths within the heart and coronary vasculature. Such integration of 3D images with remote steering is designed to make interventional procedures less cumbersome, faster and more accurate.
"This research agreement is just one part of our total solution of imaging and information technologies that address the challenges of today's increasingly busy EP labs," said Fink. "Siemens is committed to advancing this fast-growing medical field with a brave new world of diagnostic and therapeutic tools that enhance clinical and financial outcomes for our customers."
Siemens Medical Solutions of Siemens AG (NYSE:SI) , with headquarters in Malvern, Pennsylvania and Erlangen, Germany, is one of the largest suppliers to the healthcare industry in the world. The company is known for bringing together innovative medical technologies, healthcare information systems, management consulting, and support services to help customers achieve tangible, sustainable clinical and financial outcomes. Employing approximately 31,000 people worldwide and operating in more than 120 countries, Siemens Medical Solutions reported sales of 7.4 billion EUR, orders of 7.8 billion EUR, and group profit of 1.1 billion EUR for fiscal 2003.
For more information, call 425/432-9601 or visit http://www.usa.siemens.com/medical.